CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 4 Open-market sale Chief Operating Officer sold 9,000 shares at an average $14.01 ($126,100)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 1,120 shares at $14.27 ($15,982)
- 8-K Event Shareholder vote results
- 4 Open-market sale 10% owner sold 20,696 shares at $14.20 ($293,883)
- 8-K Event Material agreement
- 4 Open-market sale 10% owner sold 27,875 shares at $14.20 ($395,825)
- CT ORDER Other Confidential Order
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- ARS Other Annual Report to Security Holders
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Financial Officer sold 4,567 shares at $13.00 ($59,371)
- 8-K Event Executive or director change
Page 27 of 31 · 616 filings